Modified RECIST (mRECIST) assessment for hepatocellular carcinoma.
about
Transarterial radioembolization for hepatocellular carcinoma: a reviewSurveillance of Hepatocellular Carcinoma and Diagnostic Algorithms in Patients with Liver CirrhosisYttrium-90 Selective Internal Radiation Therapy with Glass Microspheres for Hepatocellular Carcinoma: Current and Updated Literature ReviewRecommendations for improving the quality of reporting clinical electrochemotherapy studies based on qualitative systematic review.New advances in hepatocellular carcinomaComputed Tomography and Ultrasounds for the Follow-up of Hepatocellular Carcinoma Ablation: What You Need to KnowThe Role of Diffusion-Weighted Imaging (DWI) in Locoregional Therapy Outcome Prediction and Response Assessment for Hepatocellular Carcinoma (HCC): The New Era of Functional Imaging BiomarkersCT Appearance of Hepatocellular Carcinoma after Locoregional Treatments: A Comprehensive ReviewImaging Modalities for Assessment of Treatment Response to Nonsurgical Hepatocellular Carcinoma Therapy: Contrast-Enhanced US, CT, and MRIPrediction of hepatocellular carcinoma biological behavior in patient selection for liver transplantationEvaluation of antiangiogenic efficacy in advanced hepatocellular carcinoma: Biomarkers and functional imagingPotentiality of immunotherapy against hepatocellular carcinomaUsing Modified RECIST and Alpha-Fetoprotein Levels to Assess Treatment Benefit in Hepatocellular CarcinomaUsefulness of contrast enhanced ultrasound in monitoring therapeutic response after hepatocellular carcinoma treatmentMultimodal treatment of hepatocellular carcinoma on cirrhosis: an updateAdvanced hepatocellular carcinoma and sorafenib: Diagnosis, indications, clinical and radiological follow-upCancer concepts and principles: primer for the interventional oncologist-part IRole of Transcatheter Intra-arterial Therapies for Hepatocellular CarcinomaBridging and downstaging treatments for hepatocellular carcinoma in patients on the waiting list for liver transplantationTransarterial radioembolization using yttrium-90 microspheres in the treatment of hepatocellular carcinoma: a review on clinical utility and developmentsClinical impact of ultrasound-related techniques on the diagnosis of focal liver lesions.Recent advances in multidisciplinary management of hepatocellular carcinomaNew approaches for precise response evaluation in hepatocellular carcinomaTreatment Response Evaluation and Follow-up in Hepatocellular CarcinomaThe role of interventional radiology in the management of hepatocellular carcinomaYttrium-90 radioembolization of liver tumors: what do the images tell us?Radioembolization of hepatic lesions from a radiobiology and dosimetric perspectiveTranscatheter embolization therapy in liver cancer: an update of clinical evidencesManagement of hepatocellular carcinoma: The role of contrast-enhanced ultrasoundSystematic review of catheter-based intra-arterial therapies in hepatocellular carcinoma: state of the art and future directionsRecommendations for the use of chemoembolization in patients with hepatocellular carcinoma: Usefulness of scoring system?Radioembolization with Yttrium-90 microspheres in hepatocellular carcinoma: Role and perspectivesTreatment algorithms for managing hepatocellular carcinomaFirst- and Second-Line Targeted Systemic Therapy in Hepatocellular Carcinoma-An Update on Patient Selection and Response EvaluationChallenges of advanced hepatocellular carcinomaTransarterial radioembolization for hepatocellular carcinoma: An update and perspectivesAssessment of clinical and radiological response to sorafenib in hepatocellular carcinoma patientsTroubleshooting Arterial-Phase MR Images of Gadoxetate Disodium-Enhanced Liver2014 KLCSG-NCC Korea Practice Guideline for the Management of Hepatocellular Carcinoma2014 Korean Liver Cancer Study Group-National Cancer Center Korea practice guideline for the management of hepatocellular carcinoma
P2860
Q26738273-2C86EA1D-1B4F-45E0-BEA1-1F4324C415DFQ26740317-7E5F4E68-6228-4A5B-BE78-77E79C1EB075Q26743603-D852E79E-5260-4192-A4D3-DE21AA0ABF56Q26749119-AE1CDDA6-3EB9-4E27-9A9B-CBC4F17FFE20Q26749329-558B8E09-A00F-4AE4-88B3-0B6BD5342617Q26767189-17EB2740-DD0E-45F5-8B9C-C77381D3A99FQ26768460-21DEA227-0F5C-4A6C-ACA3-80CF4A5E37D7Q26770014-1F8F9A27-30B6-4D3C-9933-007004F455ADQ26772233-1112787D-0342-4666-98CA-AD8D595E0D75Q26772329-0399232B-85F2-4400-8980-E7B0E770163EQ26783895-4D496FB6-EBAF-4037-AD4F-7D4CCA8F62BEQ26784228-04249FA9-D140-48CB-9206-513004CE5EFAQ26797535-2648E43F-734A-473D-891D-3A63CE3BFD6CQ26799914-BE364F50-2FEA-413E-ABF2-422CB93DDDD6Q26825172-C5934D33-34D4-4280-936B-B72A23B50EBFQ26851033-13C74B70-8333-4B5E-8DF7-6E8376F83CB1Q26851255-C2FDB792-C47A-47BD-B608-45D3D77B977FQ26851627-BB73E5CF-D99C-471D-867F-5F5BF63F6C80Q26852105-C5EF0C3A-C4A1-4C2E-81D2-58A4EEE5E352Q26852174-9BB70DC8-2C1D-49A2-B3C3-6A0B28F01C99Q26858872-01CE757F-1863-487A-A487-54E6ADC6D4B8Q26863748-81D6AF1B-D556-4C7A-AB3A-DCA1D9E9C905Q26866367-E09013E8-0BD0-4767-AAA1-320EEEFCA4A2Q26992004-785A240D-E413-412A-82DC-3BDA9E2D9B56Q26996805-072C10FB-2255-4522-B8C7-163833A35021Q26997064-C09A8BF5-FC7C-4FA9-A94E-D7129AD4ABA1Q26998661-D0FB3C69-A4BF-4C7C-9C37-1828E121232DQ27003849-25C5D131-ABBF-4F1F-9956-377E9B3061A1Q27005624-1C5F7B3E-565F-427A-A100-241139AD068CQ27007847-AB481A4A-B614-487A-A975-85EB056047D9Q27022015-A190D4E5-C2F6-4E4C-964A-BE9337F36789Q27023616-328E0981-5603-4A0B-8D31-BCF06EC6876DQ27027923-DBAA91C5-E680-41FF-85EB-65557E0488FDQ28073654-5EACE8F1-FADE-4139-9A10-AB1DDCD752FFQ28076867-2A687554-B6F4-4CC1-9C61-B01360F1B15BQ28081783-6FDCEE6A-BE5F-46BC-9615-7E5C28678B22Q28086977-6E0574D0-2B27-4550-89DB-4B979529B818Q28088642-623074C5-59C1-4464-B66B-1D4B97EE8B4FQ28392783-2795EAD4-B59C-4763-A94B-238EA1B3A0A6Q28394414-1C16B2FF-29AC-437E-9886-4A3FD70D994D
P2860
Modified RECIST (mRECIST) assessment for hepatocellular carcinoma.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
gotara zanistî
@ku-latn
scientific article published on 19 February 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
name
Modified RECIST (mRECIST) assessment for hepatocellular carcinoma.
@en
Modified RECIST
@nl
type
label
Modified RECIST (mRECIST) assessment for hepatocellular carcinoma.
@en
Modified RECIST
@nl
prefLabel
Modified RECIST (mRECIST) assessment for hepatocellular carcinoma.
@en
Modified RECIST
@nl
P356
P1476
Modified RECIST (mRECIST) assessment for hepatocellular carcinoma.
@en
P2093
Riccardo Lencioni
P356
10.1055/S-0030-1247132
P577
2010-02-19T00:00:00Z